Medicare utilization — LARRY DAY
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 544 | 46 | $0 | $43 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 234 | 49 | $0 | $81 |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 151 | 117 | $0 | $7,726 |
| 96372 | Injection of drug or substance under skin or into muscle | 130 | 68 | $0 | $925 |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 81 | 75 | $0 | $2,804 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·